I
Ironwood Pharmaceuticals, Inc.
IRWD · NASDAQ · Healthcare · 709M
Closing price
$3.82
-1.29% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
25.8×
Price / net assetsP/B
—
Enterprise value / EBITDAEV/EBITDA
9.6×
Free cash flow yieldFCF yield
20.5%
Return on equityROE
-9.2%
Operating margin
40.1%
Net debt / EBITDAbalance-sheet strength
3.7×
Interest coverage
3.6×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.